Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- China Medical Develops Predictor for Biologic Cancer Drug Success
Nov 20, 2008 02:38 PM
- Analyst Comments: Joy Global, Photronics, Martha Stewart, Kellogg, Red Robin, Cirrus Logic, Safeway, PACCAR, Celgene, AstraZeneca, Phase Forward, Digital River, Methanex, Grupo Televisa, HSBC, AAR Corp, Centennial, Carmike Cinema, Washington Post
Oct 10, 2008 10:10 AM
- Safe Havens in Large-Cap Pharma
Sep 23, 2008 11:41 AM
- Expiring Patents Ignite Biotech Boom
Sep 13, 2008 01:59 PM
- Another Seal of Approval For Micromet
Aug 19, 2008 10:52 AM
- Is It Time To Invest In Pharmaceuticals?
Aug 18, 2008 08:42 AM
- UK Forces Lower Drug Prices
Aug 17, 2008 07:15 PM
- NanoViricides Reports HIVCide-I May Be Functional Cure for HIV/AIDS
Aug 11, 2008 01:14 PM
- Analyst Comments: DIRECTV, Regeneron, Kimco, ASR, Atmel
Aug 06, 2008 08:31 AM
- AstraZeneca Battling Generics
Aug 04, 2008 09:00 AM
- Bizworld: Soft-Drink Makers Pursue Ancient Leaf in Bid to Reverse Falling Sales
Nov 29, 2008 07:57 AM
- London Market
Nov 28, 2008 05:16 PM
- Stock Watch ; Stocks and Shares
Nov 25, 2008 04:56 PM
- Job Cuts Mounting Worldwide ECONOMIC OUTLOOK
Nov 24, 2008 05:54 AM
- Market Watch: Analysts Prepare for the Worst As FTSE Continues Plunge
Nov 23, 2008 07:15 AM
- City Market Report
Nov 22, 2008 05:12 PM
- Stock Watch ; Stocks and Shares
Nov 22, 2008 04:56 PM
- More Pain but No Gain for Troubled Giant Woolworths
Nov 22, 2008 06:58 AM
- Further Cutbacks Unveiled Across Industry Staff Losses in UK Businesses
Nov 21, 2008 12:57 PM
- A look at economic developments around the world
Nov 20, 2008 02:17 PM
- AstraZeneca Settles US Pulmicort Respules Patent Litigation with Teva
Nov 25, 2008 03:09 PM
- MattsonJack Study Reveals Cachexia Emerging As a Lucrative Opportunity for Pharma Companies
Nov 20, 2008 11:03 AM
- Beacon Equity Issues Technical Trade Alerts on Drug Manufacturers: NVS, JNJ, PFE, GSK, ABT, AZN
Nov 20, 2008 09:20 AM
- Seven Summits Research Releases Comments on MS, MRK, UNP, AZN, and AG
Nov 19, 2008 11:22 AM
- AstraZeneca Appoints Rich Fante as President of its U.S. Business
Nov 18, 2008 10:01 AM
- MedImmune Announces Winners of Third Annual Research Abstract Competition
Nov 17, 2008 01:00 PM
- Best Practice Database Shares Best Practices in Biopharma Public Relations
Nov 13, 2008 04:00 PM
- MedImmune Announces Zook as President
Nov 13, 2008 08:02 AM
- Survey Shows Lung Cancer Patients Blamed for Their Diagnosis
Nov 12, 2008 08:02 AM
- CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin Outcomes Study
Nov 09, 2008 09:00 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
AZN
|
Compare to S&P
|
| YTD |
-11.89 %
|
44.36 %
|
| 4 Weeks |
-11.14 %
|
-3.95 %
|
| 12 Weeks |
-18.53 %
|
12.93 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -4.80 %
|
|
EPS Growth in Last Year: 30.77 %
|
|
Sales Growth in Last Quarter: -2.28 %
|
|
Sales Growth in Last Quarter: 8.74 %
|
|
|
